Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
Director departure
Appointed director
|
|
SELLAS Life Sciences Group, Inc. (SLS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/03/2023 |
4
| WOOD BARBARA A (EVP, Gen. Counsel, Corp. Sec.) has filed a Form 4 on SELLAS Life Sciences Group, Inc.|
Txns:
| Granted 20,000 shares
@ $0
Granted 80,000 options to buy
@ $3.34, valued at
$267.2k
|
|
| 02/03/2023 |
4
| Burns John Thomas (CFO) has filed a Form 4 on SELLAS Life Sciences Group, Inc.|
Txns:
| Granted 20,000 shares
@ $0
Granted 75,000 options to buy
@ $3.34, valued at
$250.5k
|
|
| 02/03/2023 |
4
| Stergiou Angelos M. (President and CEO) has filed a Form 4 on SELLAS Life Sciences Group, Inc.|
Txns:
| Granted 58,000 shares
@ $0
Granted 217,500 options to buy
@ $3.34, valued at
$726.5k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| WOOD BARBARA A (EVP, Gen. Counsel, Corp. Sec.) has filed a Form 4 on SELLAS Life Sciences Group, Inc.|
Txns:
| Sold 2,153 shares
@ $2.59, valued at
$5.6k
|
|
| 08/16/2022 |
4
| Kalin Katherine Bach (Director) has filed a Form 4 on SELLAS Life Sciences Group, Inc.|
Txns:
| Granted 19,000 options to buy
@ $3.1, valued at
$58.9k
|
|
| 08/16/2022 |
3
| Kalin Katherine Bach (Director) has filed a Form 3 on SELLAS Life Sciences Group, Inc. |
| 03/15/2022 |
4
| Francomano Robert (Chief Commercial Officer) has filed a Form 4 on SELLAS Life Sciences Group, Inc.|
Txns:
| Granted 100,000 options to buy
@ $5.23, valued at
$523k
|
|
| 03/14/2022 |
3
| Francomano Robert (Chief Commercial Officer) has filed a Form 3 on SELLAS Life Sciences Group, Inc. |
| 02/01/2022 |
4
| WOOD BARBARA A (EVP, Gen. Counsel, Corp. Sec.) has filed a Form 4 on SELLAS Life Sciences Group, Inc.|
Txns:
| Granted 13,000 shares
@ $0
Granted 48,750 options to buy
@ $5.34, valued at
$260.3k
|
|
| 02/01/2022 |
4
| Wasman Jane (Director) has filed a Form 4 on SELLAS Life Sciences Group, Inc.|
Txns:
| Granted 1,900 shares
@ $0
Granted 7,125 options to buy
@ $5.34, valued at
$38k
|
|
| 02/01/2022 |
4
| Varian John (Director) has filed a Form 4 on SELLAS Life Sciences Group, Inc.|
Txns:
| Granted 1,900 shares
@ $0
Granted 7,125 options to buy
@ $5.34, valued at
$38k
|
|
| 02/01/2022 |
4
| VAN NOSTRAND ROBERT L (Director) has filed a Form 4 on SELLAS Life Sciences Group, Inc.|
Txns:
| Granted 1,900 shares
@ $0
Granted 7,125 options to buy
@ $5.34, valued at
$38k
|
|
| 02/01/2022 |
4
| Stergiou Angelos M. (President and CEO) has filed a Form 4 on SELLAS Life Sciences Group, Inc.|
Txns:
| Granted 44,000 shares
@ $0
Granted 165,000 options to buy
@ $5.34, valued at
$881.1k
|
|
| 02/01/2022 |
4
| SCHEINBERG DAVID A (Director) has filed a Form 4 on SELLAS Life Sciences Group, Inc.|
Txns:
| Granted 1,900 shares
@ $0
Granted 7,125 options to buy
@ $5.34, valued at
$38k
|
|
| 02/01/2022 |
4
| Burns John Thomas (Senior VP, Finance & CAO) has filed a Form 4 on SELLAS Life Sciences Group, Inc.|
Txns:
| Granted 9,600 shares
@ $0
Granted 36,000 options to buy
@ $5.34, valued at
$192.2k
|
|
| 12/03/2021 |
4
| Stergiou Angelos M. (President and CEO) has filed a Form 4 on SELLAS Life Sciences Group, Inc.|
Txns:
| Sold 2,120 shares
@ $6.2509, valued at
$13.3k
|
|
| 12/03/2021 |
4
| WOOD BARBARA A (EVP, Gen. Counsel, Corp. Sec.) has filed a Form 4 on SELLAS Life Sciences Group, Inc.|
Txns:
| Sold 847 shares
@ $6.2547, valued at
$5.3k
|
|
| 12/03/2021 |
4
| Burns John Thomas (VP, Finance & Corp Controller) has filed a Form 4 on SELLAS Life Sciences Group, Inc.|
Txns:
| Sold 231 shares
@ $6.2673, valued at
$1.4k
|
|
| 12/03/2021 |
4/A
| Stergiou Angelos M. (President and CEO) has filed a Form 4 on SELLAS Life Sciences Group, Inc. |
| 12/03/2021 |
4/A
| WOOD BARBARA A (EVP, Gen. Counsel, Corp. Sec.) has filed a Form 4 on SELLAS Life Sciences Group, Inc. |
| 12/03/2021 |
4/A
| Burns John Thomas (VP, Finance & Corp Controller) has filed a Form 4 on SELLAS Life Sciences Group, Inc. |
| 03/08/2021 |
4
| WOOD BARBARA A (EVP, Gen. Counsel, Corp. Sec.) has filed a Form 4 on SELLAS Life Sciences Group, Inc.|
Txns:
| Granted 7,875 shares
@ $0
Granted 47,250 options to buy
@ $8, valued at
$378k
|
|
| 03/08/2021 |
4
| SCHEINBERG DAVID A (Director) has filed a Form 4 on SELLAS Life Sciences Group, Inc.|
Txns:
| Granted 7,500 options to buy
@ $8, valued at
$60k
|
|
| 03/08/2021 |
4
| Varian John (Director) has filed a Form 4 on SELLAS Life Sciences Group, Inc.|
Txns:
| Granted 7,500 options to buy
@ $8, valued at
$60k
|
|
| 03/08/2021 |
4
| Wasman Jane (Director) has filed a Form 4 on SELLAS Life Sciences Group, Inc.|
Txns:
| Granted 7,500 options to buy
@ $8, valued at
$60k
|
|
| 03/08/2021 |
4
| VAN NOSTRAND ROBERT L (Director) has filed a Form 4 on SELLAS Life Sciences Group, Inc.|
Txns:
| Granted 7,500 options to buy
@ $8, valued at
$60k
|
|
|
|
|